Received Mar 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 3 | y003144 | — |
No symptomatic adverse events were reported; HCP called to state that the patient received a third dose of PEDVAXHIB at 6 months of age.; This spontaneous report was received from a Nurse regarding a 6-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, past drug reactions and allergies were not reported. On 16-JAN-2025, at 6 months of age, the patient was vaccinated with the third dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) 0.5ml/series, administered as prophylaxis (lot number y003144 has been verified to be a valid number for Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) [LIQUID PEDVAX HIB], expiration date 11-SEP-2026; anatomical site of injection, formulation and route of administration were not reported) (Inappropriate schedule of product administration). No symptomatic adverse events were reported (no adverse event). This is one of several reports from the same reporter.